Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-010586
Filing Date
2024-03-01
Accepted
2024-03-01 06:02:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A ef20022939_defa14a.htm DEFA14A 166330
  Complete submission text file 0001140361-24-010586.txt   167325
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38958 | Film No.: 24706713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)